RGNT·M8211G108·US·equity·Healthcare - Medical Instruments & Supplies-13D/G
ORDINARY SHARES
RGNT (REGENTIS BIOMATERIALS LTD) is held by 1 institutional investors as of Q4 2025. Largest holders: UBS Group AG ($1,020).
See how RGNT's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer